NCT06771427 Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome
| NCT ID | NCT06771427 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Taipei Veterans General Hospital, Taiwan |
| Condition | Dry Eye Syndrome (DES) |
| Study Type | OBSERVATIONAL |
| Enrollment | 220 participants |
| Start Date | 2025-01-16 |
| Primary Completion | 2025-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 220 participants in total. It began in 2025-01-16 with a primary completion date of 2025-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
By analyzing the differential proteins in exosomes, this study aims to understand the pathological mechanisms of SJS and DES, identify potential diagnostic and therapeutic methods, and advance the diagnosis and treatment of these diseases.
Eligibility Criteria
Dry eye syndrome Inclusion Criteria: aged between 20 and 75 years Schirmer's test less than 10 mm/5 min Exclusion Criteria: Pregnancy With eye inflammation or infectious eye disease Accepted operation of eye Sjögren's syndrome Inclusion Criteria: primary or secondary SS aged between 20 and 75 years fulfilled the 2002 American-European Consensus Criteria for SS (AECG) had no abnormal findings of immune, liver, kidney, or blood function evaluations. Exclusion Criteria: a history of alcohol abuse, diabetes mellitus, or major life-threatening condition pregnancy or breastfeeding steroid pulse therapy within three months prior to the commencement of our study. non AIDDES Healthy Controls Inclusion Criteria: aged between 20 and 75 years without any Chronic disease Exclusion Criteria: any Sjögren's syndrome or Dry eye syndrome.
Contact & Investigator
Ching-Mao Chang, M.D., Ph.D.
PRINCIPAL INVESTIGATOR
Taipei Veterans General Hospital, Taiwan
Frequently Asked Questions
Who can join the NCT06771427 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 75 Years, studying Dry Eye Syndrome (DES). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06771427 currently recruiting?
Yes, NCT06771427 is actively recruiting participants. Contact the research team at magicbjp@gmail.com for enrollment information.
Where is the NCT06771427 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT06771427 clinical trial?
NCT06771427 is sponsored by Taipei Veterans General Hospital, Taiwan. The principal investigator is Ching-Mao Chang, M.D., Ph.D. at Taipei Veterans General Hospital, Taiwan. The trial plans to enroll 220 participants.